NL7402613A - - Google Patents

Info

Publication number
NL7402613A
NL7402613A NL7402613A NL7402613A NL7402613A NL 7402613 A NL7402613 A NL 7402613A NL 7402613 A NL7402613 A NL 7402613A NL 7402613 A NL7402613 A NL 7402613A NL 7402613 A NL7402613 A NL 7402613A
Authority
NL
Netherlands
Application number
NL7402613A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7402613A publication Critical patent/NL7402613A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
NL7402613A 1973-02-26 1974-02-26 NL7402613A (ref)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB924973A GB1433774A (en) 1973-02-26 1973-02-26 Heterocyclic compounds apparatus for conveying articles

Publications (1)

Publication Number Publication Date
NL7402613A true NL7402613A (ref) 1974-08-28

Family

ID=9868317

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7402613A NL7402613A (ref) 1973-02-26 1974-02-26

Country Status (14)

Country Link
JP (1) JPS5029574A (ref)
AT (1) AT329562B (ref)
AU (1) AU474797B2 (ref)
BE (1) BE811246A (ref)
CA (1) CA1025856A (ref)
CH (1) CH602707A5 (ref)
DE (1) DE2407744A1 (ref)
FR (1) FR2218896B1 (ref)
GB (1) GB1433774A (ref)
IE (1) IE38886B1 (ref)
LU (1) LU69479A1 (ref)
NL (1) NL7402613A (ref)
SE (1) SE7401984L (ref)
ZA (1) ZA74883B (ref)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2324304A2 (fr) * 1975-09-22 1977-04-15 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
US4186201A (en) 1977-02-07 1980-01-29 Riker Laboratories, Inc. Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds
US4264604A (en) 1977-07-01 1981-04-28 Ciba-Geigy Corporation Quinolonecarboxylic acid derivatives as bactericides
US4390541A (en) 1980-12-19 1983-06-28 Lilly Industries Limited Quinolone derivatives and their use in a method of controlling an immediate hypersensitivity disease
FR2509728A1 (fr) * 1981-07-17 1983-01-21 Roussel Uclaf Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
US4377579A (en) 1981-12-03 1983-03-22 Minnesota Mining And Manufacturing Company N-(Tetrazol-5-yl)phenazine-1-carboxamides
FR2537140B1 (fr) * 1982-12-07 1986-07-18 Roussel Uclaf Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant
KR960004827B1 (ko) * 1987-01-20 1996-04-16 다이닛뽄 세이야꾸 가부시끼가이샤 헤테로아릴카르복시아미드 유도체, 그의 제조방법 및 그것을 함유하는 의약조성물
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
US6034100A (en) * 1993-03-10 2000-03-07 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting cytokine secretion
US6143760A (en) 1997-08-25 2000-11-07 Neurogen Corporation Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands
PL338783A1 (en) * 1997-08-25 2000-11-20 Neurogen Corp Substituted 4-oxo-naphtyridin-3-carboxamides as ligands of cerebral gaba receptors
BR9908321A (pt) 1998-02-26 2001-12-18 Neurogen Corp Composto
NZ536061A (en) * 2002-05-14 2008-09-26 Univ California Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
WO2005009971A1 (ja) * 2003-07-24 2005-02-03 Astellas Pharma Inc. キノロン誘導体又はその塩
RU2556984C2 (ru) * 2004-06-24 2015-07-20 Вертекс Фармасьютикалз Инкорпорейтед Модуляторы транспортеров атф-связывающей кассеты
EP2502914A3 (en) * 2004-06-24 2013-12-04 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
RS56037B1 (sr) 2004-06-24 2017-09-29 Vertex Pharma Modulatori atp-vezujućih kasetnih transportera
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
EP3219705B1 (en) 2005-12-28 2020-03-11 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of the amorphous form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
PL2408750T3 (pl) 2009-03-20 2016-02-29 Vertex Pharma Sposób otrzymywania modulatorów błonowego regulatora przewodnictwa swoistego dla mukowiscydozy
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
JP2015511583A (ja) 2012-02-27 2015-04-20 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated 薬学的組成物およびその投与
JP6211509B2 (ja) 2012-03-02 2017-10-11 武田薬品工業株式会社 複素環化合物およびその用途
WO2014077401A1 (ja) 2012-11-19 2014-05-22 武田薬品工業株式会社 含窒素複素環化合物
CN107250113B (zh) 2014-10-07 2019-03-29 弗特克斯药品有限公司 囊性纤维化跨膜传导调节蛋白的调节剂的共晶
CN105330602B (zh) * 2015-12-07 2018-02-09 江南大学 一种癸氧喹酯类似物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1383088A (en) * 1972-07-03 1975-02-05 Allen & Hanburys Ltd Pharmacologically active quinaldamide derivatives

Also Published As

Publication number Publication date
JPS5029574A (ref) 1975-03-25
CH602707A5 (ref) 1978-07-31
LU69479A1 (ref) 1975-05-21
SE7401984L (ref) 1974-08-27
GB1433774A (en) 1976-04-28
AU474797B2 (en) 1976-08-05
BE811246A (fr) 1974-08-19
FR2218896A1 (ref) 1974-09-20
AT329562B (de) 1976-05-25
AU6559274A (en) 1975-08-14
IE38886L (en) 1974-08-26
FR2218896B1 (ref) 1977-09-09
DE2407744A1 (de) 1974-08-29
ATA149974A (de) 1975-08-15
ZA74883B (en) 1974-12-24
IE38886B1 (en) 1978-06-21
CA1025856A (en) 1978-02-07

Similar Documents

Publication Publication Date Title
AR201758A1 (ref)
AU476761B2 (ref)
AU465372B2 (ref)
AR201235Q (ref)
AR201231Q (ref)
AU474593B2 (ref)
AU474511B2 (ref)
FR2218896A1 (ref)
AU474838B2 (ref)
AU471343B2 (ref)
AU465453B2 (ref)
AU465434B2 (ref)
AU450229B2 (ref)
AU476714B2 (ref)
AR201229Q (ref)
AU466283B2 (ref)
AR199451A1 (ref)
AU476696B2 (ref)
AU472848B2 (ref)
AU477823B2 (ref)
AR200885A1 (ref)
AR195311A1 (ref)
AR200256A1 (ref)
AR201432A1 (ref)
AU477824B2 (ref)

Legal Events

Date Code Title Description
BV The patent application has lapsed